An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone
暂无分享,去创建一个
[1] J. Vander,et al. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR) , 2017, Retina.
[2] S. Bakri,et al. Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. , 2018, Survey of ophthalmology.
[3] A. Loewenstein,et al. Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study , 2017, Acta ophthalmologica.
[4] Z. Nagy,et al. MINERALOCORTICOID RECEPTOR ANTAGONIST TREATMENT IN BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A COMPARATIVE STUDY OF EXUDATIVE AND NONEXUDATIVE FELLOW EYES , 2017, Retina.
[5] D. Eliott,et al. Systemic Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy , 2017, Seminars in ophthalmology.
[6] Jesse J. Jung,et al. CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY , 2016, Retina.
[7] C. Regillo,et al. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. , 2015, Ophthalmic surgery, lasers & imaging retina.
[8] H. Ghanbari,et al. Central serous chorioretinopathy following kidney transplantation. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[9] Min Zhao,et al. MINERALOCORTICOID RECEPTOR ANTAGONISM IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2013, Retina.
[10] Aman Sharma,et al. Dark Spot in Fibrinous Central Serous Chorioretinopathy Masquerading Choroiditis , 2013, Ocular immunology and inflammation.
[11] Min Zhao,et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. , 2012, The Journal of clinical investigation.
[12] F. Pakdel,et al. Hyperthyroid vs hypothyroid eye disease: the same severity and activity , 2011, Eye.
[13] K. Kumar,et al. Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease , 2009, Postgraduate Medical Journal.
[14] D. Eliott,et al. Optical coherence tomographic findings in pregnancy-associated central serous chorioretinopathy , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[15] J. Melby,et al. Endocrine abnormalities in patients with central serous chorioretinopathy. , 2003, Ophthalmology.
[16] A. Sari,et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium. , 2001, Investigative ophthalmology & visual science.
[17] C. Schmid,et al. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. , 2000, Retina.
[18] J. Gass,et al. Idiopathic central serous chorioretinopathy. , 1998, Indian journal of ophthalmology.
[19] M. Kaiser-Kupfer,et al. Central serous chorioretinopathy in endogenous hypercortisolism. , 1993, Archives of ophthalmology.
[20] A. Lassus,et al. Systemic side-effects of three topical steroids in diseased skin. , 1983, Current medical research and opinion.
[21] R. Frank,et al. Central serous retinopathy and pregnancy. , 1974, American journal of ophthalmology.
[22] P. Kadowitz,et al. Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. , 1974, European Journal of Pharmacology.
[23] J D Gass,et al. Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.